70 results
424B5
5rb fr8hnqj2vgn3
26 Jan 24
Prospectus supplement for primary offering
4:08pm
424B5
2n16o5k8 jn2yo
24 Jan 24
Prospectus supplement for primary offering
9:20pm
8-K
EX-99.3
iiusb nzsrhyqsvl094
24 Jan 24
Results of Operations and Financial Condition
5:10pm
8-K
EX-99.1
g7in5r
24 Jan 24
Results of Operations and Financial Condition
5:10pm
8-K
EX-99.1
vh3w4m69g71z 3v2
8 Jan 24
Regulation FD Disclosure
9:19am
8-K
EX-10.7
sy6s1cy
19 Oct 23
Tourmaline Bio Announces Closing of Merger with Talaris Therapeutics and Concurrent Private Placement of $75 Million
9:11pm
8-K
vdecfizd
17 Oct 23
Talaris Therapeutics Announces Stockholder Approval of Merger with Tourmaline Bio
6:35pm
8-K
EX-99.1
wmvwc9d46mp38
17 Oct 23
Talaris Therapeutics Announces Stockholder Approval of Merger with Tourmaline Bio
6:35pm
425
qoitti 7940jy4ky45z8
26 Sep 23
Business combination disclosure
8:24am
8-K
EX-99.1
tlmw1e j1mh9ek
26 Sep 23
Regulation FD Disclosure
8:21am
424B3
oj9fiawygqdwkf vdcm
15 Sep 23
Prospectus supplement
6:31am
425
px688a2
13 Sep 23
Business combination disclosure
9:14am